Price
chg
chg neg
quotes and stock data may be delayed 15 minutes
My Notes
Only BPIQ Pro members can create company notes. Learn more here.
52 wk low
low api
52 wk hi
high api
Cash
$1.53B
Burn Rate (Qtr)
$222.6M
Mkt Cap
mkt cap api
Avg Volume
volume api
*cash/burn updated:
Q4 '22
Drug Pipeline
Click the button to see the updated pipeline
No drug found
We don't have any drug data for this company yet
Drug | Disease (links)
Stage (next event)
Catalyst Date
Loading Catalysts...
search in progress
Pipeline powered by
ROIV
Company Profile
Roivant Sciences Ltd. focuses on discovery, development, and commercialization of medicines. It develops transformative medicines by building technologies and developing talent in creative ways, leveraging its platform to launch Vants – nimble and focuses biopharmaceutical and health technology companies. The company was founded in 2014 and is based in London, the United Kingdom.
Recent Posts
See what the community is saying - click to see full post.